PROS1 and cancer: Abnormally enhanced expression of pro-survival proteins and reduced expression of pro-apoptotic proteins can help cancer cells to evade apoptosis and largely contribute to the development of resistance to therapies, but growing evidence also indicates that these cancer cell- and/or drug-driven disturbances might also create apoptotic vulnerabilities that can be determined and potentially therapeutically exploited (recently reviewed in [42]).